Sign in / Join Now
ETFs & Funds
Street Mixed On Galectin's Therapeutics NASH Drug $
Add a reply...
Latest StockTalks »
people get GALT breaking news and analysis by email alert.
Get email alerts on GALT »
Galectin Therapeutics, Inc.
Get latest price
From other sites
Galectin Therapeutics Announces Results From 12-Week Extension Of Phase 2a Psoriasis Clinical Trial
at TheStreet (Thu, 8:00AM)
Galectin Therapeutics Reports Second Quarter 2016 Financial Results And Provides Business Update
at TheStreet (Aug 9, 2016)
Galectin Therapeutics Announces Completion Of Patient Recruitment In Its Phase 2 Trial With GR-MD-02 In NASH Patients With Cirrhosis
at TheStreet (Aug 2, 2016)
Galectin Therapeutics (GALT) Jumps: Stock Rises 17.1%
at Zacks.com (Aug 2, 2016)
Research Underlying Galectin's Development of GR-MD-02 in Cancer Presented at the Society for Immunotherapy of Cancer Annual Meeting
at 4-traders.com (Nov 11, 2015)